This study sheds light on the challenges for real-world patients of staying on these medications and highlights the need to tackle barriers such as cost, insurance coverage, and equitable policies to ensure availability
An earlier study published in Nature Medicine in January 2025 mapped the benefits and risks of GLP-1 drugs across 175 health outcomes in more than 2 million veterans, finding reduced risks for dementia, Alzheimers disease, psychotic disorders and seizures alongside known risks for pancreatitis and kidney problems
Khatoon H, Sahana NS, Suresh T, Tahasildar J, Renuga S, Kulkarni M
What does it mean when the leader you are fighting for is racially half white and you end up talking about the skin color of his principal opponent
I started with 0.03ml then 0.05ml now 0.07ml